7Kim D S.Interstitial lung disease in rheumatoid arthritis:recent advances[J].Curr Opin Pulm Med,2006,12(5):346-53.
8Kim Y K,Lee K S,Chung M P,et al.Pulmonary involvement in Churg-Strauss syndrome:an analysis of CT,clinical,and pathologic findings[J].Eur Radiol,2007,17(12):3157-65.
9Ghio A J,Churg A,Roggli V L.Ferruginous bodies:implications in the mechanism of fiber and particle toxicity[J].Toxicol Pathol,2004,32(6):643-9.
1Sugiyama Y, Kudoh S, Urabe A, et al. Analysis of peripheral lymphocyte subsets in patients with diffuse panbronchiolitis. Nihon Kyobu Shikkan Gakkai Zasshi, 1984, 22:1116-1121.
2Mukae H, Hirota M, Kohno S, et al. Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis,1993,148:744-751.
3Homma S, Kawabata M, Kishi K, et al. Diffuse panbronchiolitis in rheumatoid arthritis. Eur Respir J, 1998, 12: 444-452.
4Ono K, Shimamoto Y, Matsuzaki M, et al. Diffuse panbronchiolitis as a pulmonary complication in patients with adult T-cell leukemia. Am J Hematol, 1989, 30:86-90.
5Kido T, Yamamoto F, Ookubo N, et al. A case of primary lung cancer associated with diffuse panbronchiolitis. Kyobu Geka, 1989, 42:409-412.
6Okano A, Sato A, Suda T,et al. A case of diffuse panbronchiolitis complicated by malignant thymoma and Sjogren′s syndrome. Nihon Kyobu Shikkan Gakkai Zasshi, 1991,29:263-268.
7Wales D,Woodhead M. The anti-inflammatory effects of macrolides. Thorax,1999,54 Suppl 2:s58-s62.
8Park MH, Kim YW, Yoon HI, et al.Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients.Am J Respir Crit Care Med, 1999,159:526-529.
9Matsuzaka Y,Tounai K,Denda A,et al. Identification of novel candidate genes in the diffuse panbronchiolitis critical region of the class I human MHC. Immunogenetics, 2002,54: 301-309.
3King G G, Salome C M. Muhimodahty measurements of small air- ways disease [J]. Eur Respir J,2006,27(2) :250-252.
4Sturton G, Persson C, Barnes P J. Small airways:an important but neglected target in the treatment of obstructive airway diseases [ J ]. Trends Pharmacol Sci, 2008,29 (7) : 340-345.
5Martin-Loeehes I, Artigas A, Gordo F, et al. Current status of fibreoptic bronchoscopy in intensive care medicine. Med Intensi- va, 2012,36(9):644-649.
6Nair A, Godoy MC, Holden EL, et al. Multidetector CT and postprocessing in planning and assisting in minimally invasive bronchoscopic airway interventions. Radiographics, 2012,32(5): 201-232.
7Gibbs JD, Graham MW, Higgins WE. 3D MDCT-based system for planning peripheral bronchoscopic procedures. Comput Biol Med, 2009,39(3) :266-279.
8Lv J, Wu J, Guo R, et al. Laboratory test of a visual sputum suctioning system. Respir Care, 2013,58(10):1637-1642.
9Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med, 2011,184(2) :159-171.
10Cappuzzo F, Bartolini S, Crino L. Emerging drugs for non-small cell lung cancer. Expert Opin Emerg Drugs, 2003,8(1) :179-192.
